An international collaboration has shown proof-of-concept that truly personalized therapy will be possible in the future for people with cancer. Details of how a knowledge bank could be used to find the best treatment option for people with acute myeloid leukemia are published in a new report.
(Johns Hopkins Medicine) A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.
Melanoma is the most dangerous type of skin cancer with the strongest increase in incidence in the last decade, and the incidence rates have never been as high. The World Health Organization based International Agency for Research on...Show More Summary
A prostate specific antigen (PSA) nadir greater than 0.5 ng/mL following radiation and androgen deprivation therapy appears to identify men prior to PSA failure who are at high-risk for dying early as a result of treatment failure for their prostate cancer, research shows.
New research has uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study findings suggest small cell lung cancer should not be treated as a uniform disease.
A knitted rag sock inspired this professor and MD to develop a stent that can easily be removed after it has done its job.
(American Cancer Society) Six outstanding individuals have been honored with the American Cancer Society Lane W. Adams Quality of Life Award, a prestigious national honor for their leadership in serving the complex needs of cancer patients and their families.
Chloroquine – a drug currently used to treat malaria – may be useful in treating patients with metastatic cancers, a new study suggests.
Some cancer cells are protected from radiation therapy through an interaction of interleukin-6 with the Nrf2-antioxidant pathway, researchers have found. The discovery is believed to improve methods of increasing cancer's radiosensitivity.
(Kumamoto University) Researchers from Kumamoto University in Japan have discovered that some cancer cells are protected from radiation therapy through an interaction of interleukin-6 with the Nrf2-antioxidant pathway. The discovery is believed to improve methods of increasing cancer's radiosensitivity.
Researchers report surprising results of experiments intended to explore the consequences of having too many or too few chromosomes, a phenomenon that biologists call aneuploidy. They were surprised to find that having one extra chromosome actually supresses cancer, contrary to long-held belief.
Scientists have discovered a protein that fine-tunes the cellular clock involved in aging.
A new therapy in development for the treatment of midgut neuroendocrine tumors, a rare type of cancer that occurs in the small intestine and colon, shows improved progression-free survival and response rates for patients with advanced disease.
(University of Chicago Medical Center) The newer e-cigarette vape pens (AKA vaporizers) may not look like cigarettes, but they stimulate the urge to smoke as powerfully as watching someone smoke a traditional tobacco cigarette.
(University of Utah Health Sciences) New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Show More Summary
(Columbia University Medical Center) Collaboration will investigate the efficacy of a system biology approach to identifying treatment options for patients with advanced gastrointestinal stromal tumors.
In a perspective article, a researcher addresses the need for – and the barriers preventing – electronic reporting of patients’ symptoms between visits.
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study, researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- and tumor-fighting capabilities of the immune system.
(UNC Lineberger Comprehensive Cancer Center) In a perspective published in the New England Journal of Medicine, UNC Lineberger Comprehensive Cancer Center researcher Ethan Basch, M.D., M.Sc., addressed the need for -- and the barriers preventing -- electronic reporting of patients' symptoms between visits.
(H. Lee Moffitt Cancer Center & Research Institute) Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science...Show More Summary